Managing the returns & reconciliation challenges of a Direct to Patient distribution model
Effective recruitment and retention is a fundamental building block of successful clinical trials management. It is also a large cost centre, with drug manufacturers investing an estimated $2.28 billion each year in recruiting study participants. Despite this, around two-thirds of clinical sites fall short of their enrollment quotas and the rate of patient drop-outs remains at approximately 30%.
This has given rise to a renewed industry focus on patient centricity. Promoting a positive patient experience is no longer just a moral obligation for sponsors, it’s a commercial one too. If recruitment is appropriately incentivised and patient convenience championed, enrollment can be accelerated, drop-outs and delays reduced, and revenues maximised.
Download this Case Study to find out more
View Resource